Marker Therapeutics, Inc.
MRKRNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for MRKR. That does not mean none is planned.
Get an email about MRKR's next catalysts
Track Marker Therapeutics (MRKR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
MRKR Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.12 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Low dose FRα vaccine
Breast Cancer
TPIV200
Ovarian Cancer
High dose FRα vaccine
Breast Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Low dose FRα vaccine | Phase 2 | Breast Cancer | - | - |
TPIV200 | Phase 2 | Ovarian Cancer | - | - |
High dose FRα vaccine | Phase 2 | Breast Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Marker Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Marker Therapeutics, Inc.'s (MRKR) pipeline across Phase 2. Its lead program is High dose FRα vaccine (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Marker Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Marker Therapeutics, Inc. (MRKR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MRKR biotech catalysts?→
Add MRKR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Marker Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.